You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Suppliers and packagers for POTASSIUM CHLORIDE 0.075% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER


✉ Email this page to a colleague

« Back to Dashboard


POTASSIUM CHLORIDE 0.075% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
B Braun POTASSIUM CHLORIDE 0.075% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER potassium chloride; sodium chloride INJECTABLE;INJECTION 019708 NDA B. Braun Medical Inc. 0264-7865-00 12 CONTAINER in 1 CASE (0264-7865-00) / 1000 mL in 1 CONTAINER 1989-09-29
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers for the Pharmaceutical Drug: Potassium Chloride 0.075% in Sodium Chloride 0.9% in Plastic Container

Last updated: August 7, 2025


Overview

Potassium chloride (KCl) in a 0.075% concentration, diluted in a 0.9% sodium chloride (NaCl) solution, is a vital intravenous (IV) fluid used primarily for electrolyte replenishment, correction of hypokalemia, and fluid therapy. The packaging typically involves plastic containers, such as prefilled bags, owing to safety, sterility, and convenience. This article explores the key suppliers, market landscape, and considerations for sourcing this specific pharmaceutical product.


Market Demand and Usage

The demand for potassium chloride solutions arises from hospitals, clinics, and infusion therapy providers worldwide. Given its application in critical care, electrolyte management, and hydration therapies, the supply chain must ensure consistent quality, sterile conditions, and regulatory compliance across different regions.

Key Suppliers in the Global Market

1. Baxter International Inc.

Baxter is a leading global producer of IV fluids, including potassium chloride solutions. Their "Baxter KCl" products are widely available, with formulations in plastisol bags or bottles. Their manufacturing facilities adhere to strict Good Manufacturing Practices (GMP) and are approved by major regulatory authorities, such as the FDA and EMA.

  • Product details: Potassium chloride 0.075% in sodium chloride 0.9%, in polyethylene or PVC-lined plastic containers.
  • Availability: North America, Europe, Asia-Pacific, and other regions.

2. B Braun Melsungen AG

B. Braun supplies a comprehensive range of IV fluids, including potassium chloride solutions. Their "Sterofund" series is well recognized globally.

  • Product specifics: Prepared for infusion in sterile plastic containers, compatible with automated infusion systems.

  • Distribution: Europe, North America, and emerging markets.

3. Hospira (a Pfizer company)

Hospira’s portfolio features various electrolyte solutions, including potassium chloride in saline. Their "Hospira KCl" solutions meet high safety standards.

  • Market presence: U.S., Canada, and global markets through authorized distributors.

4. Fresenius Kabi

Fresenius offers IV solutions for electrolyte management, including potassium chloride in 0.9% sodium chloride infusion bags.

  • Special features: Designed for compatibility with infusion pumps; high-quality, sterile packaging.

  • Delivery regions: Europe, Asia-Pacific, Latin America.

5. Local and Regional Manufacturers

In addition to global giants, several regional manufacturers produce potassium chloride solutions, often supplying domestic markets with competitive pricing and compliance with local regulatory standards. Examples include:

  • Dr. Reddy’s Laboratories (India)

  • Shijiazhuang No. 4 Pharmaceutical Co., Ltd. (China)

  • Hainan Yew Pharmacy (China)

The regional producers often obtain WHO-GMP certification or local health authority approval, ensuring product quality.


Regulatory and Quality Considerations

When sourcing potassium chloride solutions, especially in critical healthcare settings, procurement should prioritize suppliers with:

  • GMP compliance and certifications from agencies such as the FDA, EMA, or local regulators.

  • Certificate of Analysis (CoA) verifying endotoxin levels, sterility, pH, and potassium chloride concentration.

  • Batch traceability and robust supply chain transparency.

  • Packaging integrity: Ensuring containers prevent contamination and maintain sterility.


Distribution Channels and Procurement Strategies

Procurement generally involves direct negotiations with manufacturers, authorized distributors, or pharmaceutical wholesalers. For high-volume needs, establishing direct supplier relationships ensures prioritize delivery and competitive pricing.

  • Global procurement platforms such as McKesson, AmerisourceBergen, and Cardinal Health offer access to multiple suppliers.

  • Regional distributors serve localized markets, often providing warehousing solutions.

  • Contract manufacturing organizations (CMOs) may also produce custom formulations per client specifications, adhering to quality standards.


Innovations and Future Considerations

Emerging trends in the pharmaceutical supply chain include:

  • Enhanced sterilization techniques and single-use, prefilled plastic containers which simplify storage and administration safety.

  • Automation and real-time supply chain monitoring, reducing shortages and ensuring compliance.

  • Regional manufacturing expansion to reduce reliance on supply chains distant from end-users.

  • Regulatory convergence facilitating easier approval processes across markets.


Conclusion

The supply of potassium chloride 0.075% in sodium chloride 0.9% infusion in plastic containers is dominated by a handful of established global manufacturers, notably Baxter, B. Braun, Hospira, and Fresenius Kabi. Regional players complement the market by providing locally produced options. Ensuring product quality involves verifying GMP compliance, authentic certification, and consistent batch testing. Strategic procurement involves balancing cost, supply security, and regulatory adherence, with digital platforms playing an expanding role in supply chain optimization.


Key Takeaways

  • Top-tier global suppliers include Baxter, B. Braun, Hospira, and Fresenius Kabi, offering reliable access to high-quality potassium chloride infusion solutions.

  • Regional manufacturers provide cost-effective and locally compliant options, suitable for domestic healthcare systems.

  • Procurement should emphasize regulatory compliance, batch testing, and packaging integrity to mitigate risks.

  • Innovation in packaging and supply chain technologies enhances safety, efficiency, and responsiveness.

  • Building strong relationships with multiple suppliers and leveraging digital procurement platforms can ensure stable supply, especially amid global disruptions.


FAQs

1. What are the main regulatory standards for sourcing potassium chloride infusion solutions?
Regulatory standards require GMP compliance, sterility, proper labeling, and certificates of analysis. Suppliers should hold certifications from agencies like the FDA, EMA, or equivalent local authorities.

2. How can healthcare providers verify the authenticity of potassium chloride solutions?
Verification through batch-specific certificates of analysis, supplier accreditation, and inspection of packaging integrity ensures authenticity and quality.

3. Are regional manufacturers as reliable as global brands for this medication?
Yes, provided they meet certified GMP standards and have proper regulatory approvals, regional manufacturers can be equally reliable for supply and quality.

4. What factors influence the pricing of potassium chloride solutions?
Pricing depends on production complexity, regional manufacturing costs, regulatory compliance, volume volume discounts, and distribution logistics.

5. How is supply chain disruption mitigated for critical drugs like potassium chloride?
Diversifying suppliers, maintaining strategic stockpiles, establishing long-term contracts, and leveraging digital procurement platforms help mitigate risks.


References

[1] Baxter International Inc. Product Catalog.
[2] B. Braun Melsungen AG. Infusion Solutions.
[3] Hospira. IV Fluid Portfolio.
[4] Fresenius Kabi. IV Solutions Information.
[5] World Health Organization (WHO). Guidelines on the quality, safety, and efficacy of pharmaceuticals.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.